Drug intelligence / Profile preview

Inteliphage

Development stage
Preclinical
Lead developer
Inteliphage
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
01

Overview

Inteliphage (formerly Vésale Bioscience) is a personalized phage therapy platform designed to treat antimicrobial-resistant (AMR) bacterial infections. The platform utilizes a proprietary automated diagnostic tool called the Phagogram to rapidly identify the most effective combination of bacteriophages from a GMP-certified library for a specific patient's infection. These selected bacteriophages are then formulated as tailored magistral preparations. The mechanism of action involves the bacteriophages specifically binding to, infecting, and lysing pathogenic bacteria, often in synergy with conventional antibiotics to overcome resistance. This precision medicine approach represents an innovative modality for treating bacterial infections where standard antibiotic treatments have failed.

Other names
Personalized phage therapy platformVésale Bioscience phage therapyPhagogram-based phage therapy
02

Targets

Klebsiella pneumoniae surface antigensSpA (Staphylococcal protein A)

Beyond the preview

Go deeper on Inteliphage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inteliphage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call